Both in Blank Checks
Xterax Corporation II vs Drugs Made In America Acquisition
Over the past year XTER returned −0.5% and DMAA returned +0.8%; their daily moves had a correlation of 0.03.
XTER −0.5% DMAA +0.8%Growth of $1, one year, split-adjusted
| Metric | XTER | DMAA |
|---|---|---|
| Price | $9.77 | $10.89 |
| Market cap | $266.9M | $264.4M |
| Today | 0.00% | +0.09% |
| 1 month | −0.2% | +0.5% |
| 6 months | — | +2.7% |
| Year to date | — | +5.0% |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | -$329.7K |
| Dividend yield | — | — |
| Volatility (60d) | — | 1.8% |
| Short % of float | 0.0% | 0.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).